Research is being conducted on the use of extracorporeal life support in treating infarct-related cardiogenic shock. The effectiveness and safety of this treatment approach are being examined, with some studies investigating specific factors such as the impact of resuscitated cardiac arrest and the use of certain medications. The outcomes of these studies appear to be mixed, with some suggesting that extracorporeal life support may not be as beneficial as previously thought, while others continue to explore its potential benefits and optimal usage.